Quantcast

Latest Diabetes mellitus type 1 Stories

2014-03-12 11:32:47

The interactions of the gut microbiota in children with typical diabetes autoantibodies differ from that in healthy children. The fact that these differences already exist before antibodies are detectable in the blood adds to the growing evidence that microbial DNA, the so-called microbiome, may be involved in the development of autoimmune processes. Scientists from the Helmholtz Zentrum München have published their findings in the specialist journal Diabetes. As part of the BABYDIET...

2014-03-12 00:22:31

DUBLIN, Ireland, March 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/pxhxkq/continuous ) has announced the addition of the "Continuous Glucose Monitoring Market - Forecasts to 2019" [http://www.researchandmarkets.com/research/pxhxkq/continuous ] report to their offering. <start_newscom> (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The rapid rise in diabetic population across the globe has...

How To Make Insulin-producing Cells From Gut Cells
2014-03-11 17:26:17

University of Pennsylvania School of Medicine Destruction of insulin-producing beta cells in the pancreas is at the heart of type 1 and type 2 diabetes. "We are looking for ways to make new beta cells for these patients to one day replace daily insulin injections," says Ben Stanger, MD, PhD, assistant professor of Medicine in the Division of Gastroenterology, Perelman School of Medicine at the University of Pennsylvania. Transplanting islet cells to restore normal blood sugar levels in...

2014-03-11 08:30:59

JERUSALEM, March 11, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that IP Australia, the Australian government's patent office, has issued the Company its third patent in the country. The patent, titled "Methods and Compositions for Oral Administration of Exenatide," covers oral exenatide compositions made using the company's...

2014-03-11 08:30:21

Special fund established to support initiatives for grandparents of, parents of, and young people living with diabetes BERKELEY, Calif., March 11, 2014 /PRNewswire-iReach/ -- The Diabetes Hands Foundation now hosts GrandmaSandy.com among its online sites and has established the Grandma Sandy Fund. This special fund, named in honor of "Grandma Sandy" Hollenberg, will support initiatives and activities aimed at grandparents of, parents of, and young people living with diabetes. Sandy...

2014-03-10 23:00:46

Katz & Phillips, P.A. law firm strives to help law students through an annual scholarship fund. (PRWEB) March 10, 2014 The law office of Katz & Phillips, P.A., announced today the creation of an annual scholarship to benefit law school students with type I diabetes. Katz & Phillips has worked with various organizations in the past to help raise funds for diabetes research and a cure. Last year Katz & Phillips, P.A., participated in the American Diabetes Association’s...

2014-03-10 04:21:04

LEUVEN, Belgium, March 10, 2014 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a EUR3 million grant from the Flemish agency for Innovation by Science and Technology (IWT). The grant funding will be used by ThromboGenics to support research into potential new biotherapeutics for the...

2014-03-06 16:27:33

SAN DIEGO, March 6, 2014 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® Insulin Pump, today reported its financial results for the quarter and year ended December 31, 2013. http://photos.prnewswire.com/prnvar/20131220/LA37333LOGO For the year ended December 31, 2013, sales were $29.0 million compared to $2.5 million for the same period of 2012. Commercial sales of the t:slim Insulin Pump and related supplies...

2014-03-06 08:31:53

Presentations Scheduled at Barclays Global Healthcare Conference, BioPharma Asia Convention and ROTH Growth Stock Conference in March JERUSALEM, March 6, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com [ \\lonpivdocs\Aviva - Oramed\EFN Synced Tool\.CORPORATE\Public Relations\Press Releases\Press Releases\2014\NEW RELEASES - checking\www.oramed.com ]), a clinical-stage pharmaceutical company focused on the development of oral drug...

Genetic Mutation Found That Lowers Odds Of Developing Diabetes
2014-03-03 13:18:59

Brett Smith for redOrbit.com - Your Universe Online A massive new study from a team of international researchers has identified mutations in a gene that can significantly reduce the risk of developing type 2 diabetes – regardless of risk factors such as old age and being overweight. Seen in patients from multiple ethnic groups, the results showed a drug that imitates the influence of these mutations could be effectively used around the world. In the study published in Nature Genetics...


Latest Diabetes mellitus type 1 Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

More Articles (1 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related